My name is Darlene Kriewald, you see me in your lives as joybites with Darlene. I have several questions: I was on tirz - stalled on the weight loss at the max dose - I started Reta - it's a slow gradual weight loss with fluctuations. I am 70 years old - based on your knowledge, would I be better off staying with Reta - adding Ellie - or going back to Tirz - adding Ellie? I would like to start with Klow - I was on GHK-CU but honestly, the person I bought it from wasn't helpful and I'm disappointed in what it was supposed to do for me. I think I would like Klow. The other item - yesterday you were discussing the peptide that aides in bags under eyes and wrinkles. What was that peptide? I am interested in purchasing that as well. Any assistance would be greatly appreciated. I know you can only give your opinions and I am anxious to hear your recommendations.

Glow family, let’s talk about a name you may be hearing more often: ELORALINTIDE. 💛 Quick naming update: we have renamed our listing on glowglps.com “Ellie.” Eloralintide is still the scientific name to use when looking up the research. Ellie is our site’s name, not an approved medicine brand or a Lilly endorsement. 🧠 WHAT IS IT? Eloralintide is an investigational selective amylin receptor agonist. In plain English, researchers are studying how it activates a pathway involved in feeling full. It works through a different receptor pathway from GLP-1 medicines. 🔬 WHY THE INTEREST? In a 48-week Phase 2 trial involving 263 adults with obesity or overweight and a related health condition, without type 2 diabetes, eloralintide groups had average weight reductions ranging from 9.5% to 20.1%, versus 0.4% with placebo. Those results were published in The Lancet in 2025. Gastrointestinal symptoms and fatigue were the most common adverse events. 📰 THE LATEST HEADLINE — SEPTEMBER 30, 2026 Lilly reported a separate 48-week Phase 2b study in 367 adults with obesity or overweight AND type 2 diabetes. The highest-dose eloralintide-plus-tirzepatide group had an average 23.3% weight reduction, compared with 14.8% for tirzepatide alone. That 23.3% figure is for the COMBINATION—not eloralintide alone. The headline percentages above use an analysis estimating results if participants remained on treatment; they are not guaranteed individual outcomes. ⚖️ WHAT ELSE SHOULD WE KNOW? In the combination study, gastrointestinal side effects were more frequent with the combination. Across combination groups, 10.8%–27.0% stopped treatment because of adverse events, versus 2.9% with tirzepatide alone. That matters alongside the weight-loss headline. Eloralintide remains investigational, with Phase 3 studies underway. Longer-term safety and effectiveness still need study. These trials evaluated Lilly’s study medicine; they do not establish the identity, quality, safety, or effectiveness of a product sold under the name Ellie.

I’m so glad you’re here. Glow Lab was created for women 40+ who are curious about metabolism, energy, longevity science, and peptide research. Many of us reach a point where our bodies start changing and we’re told, “That’s just aging.” Here, we explore the science behind what’s really happening and what researchers are discovering about how the body works. This community is a place for: • learning about metabolism and mitochondrial energy • exploring peptide and longevity research • asking questions and sharing discoveries • supporting each other in becoming healthier and more vibrant You don’t need to be an expert. Just bring curiosity. --- ✨ Start here with these three steps: 1️⃣ Introduce Yourself Tell us where you’re from and what made you curious about Glow Lab. 2️⃣ Visit the Classroom Go to Classroom → “Start Here: Welcome to Glow Lab” to begin the Glow Lab University lessons. 3️⃣ Check the Calendar Join our upcoming live sessions where we talk about metabolism, peptides, and longevity science together. --- 🌿 Community vibe This is a respectful, supportive space. Curiosity is encouraged, questions are welcome, and everyone is learning together. --- ✨ Introduce yourself below! Where are you joining from and what made you curious about metabolism or peptide sci